The search for regenerative treatments for damaged hearts due to disease has long been impeded by the difficulty of stem cells achieving maturity into more adult-like heart cells. The discovery of a molecular switch that seems to help embryonic heart cells transform from glucose into metabolism based on fatty acids, and into a bigger, stronger, mature heart cells. According to scientists, this would possibly make way for lab methods to be able to grow hearts cells. These discoveries were made by scientists that carry ACLS certification online. ACLS certifcation online is often time required for the doctor or scientist that is performing research.
In the particular interest in stem cell and regenerative medicine, researchers and scientist should gain better understanding of how human hearts mature. This breakthrough finding has the potential to lead to innovative laboratory methods for creating heart cell functions. It has been described on paper in the May 11 Proceedings of the Natural Academy of Sciences.
Professor of biochemistry and senior writer of the paper at the University of Washington, Hanelle Ruohola-Baker believes that they have discovered the master switch responsible for the maturation process, allowing them to induce embryonic stem cells into becoming heart cells.
In the months prior to giving birth and the months that follow, an infant’s heart cells may undergo significant changes. Cells may enlarge, develop complex elements that promote contraction, and may switch from a glucose based metabolism energy into fat based metabolism. These changes yield changes such as a bigger and stronger heart of a newborn.
In the recent study, Kavitha T. Kuppusamy who is lead author and senior head of the lab, executed a transcriptone analysis of RNA. Kuppusamy and Ruohola-Baker both had their best interest in a subset of molecules referred to as microRNA. These are able to control genes, individual expressions, and regulating cell growth, development and function. It was under these circumstances that a 20-day old human embryonic system is utilized, coming from cell-derived cardiomyocytes and the more mature versions of the cells. Generally, it deals with the kind of analysis and details the RNA types and levels produce.
Comparing the 20-day old from more mature 13 -year old cardiomyocytes, the let-7 microRNA was ost remarkable according to Kuppusamy. Though other microRNAs have elevated levels in more mature cells, let-7 multiplied a thousand fold. It affects a number of key genes which regulate glucose metabolism known as the PI3, AKT or insulin pathway.
Kuppusamy and her colleagues further explored the effects that raising and lowering let-7 levels has upon the hECS-CMs. Decreasing let-7 levels make cells revert to glucose based and because smaller, less mature and weaker. Increasing levels made cells switch into fatty-acid based metabolism, became larger and stronger , and more mature.
On top of its effect on insulin pathway, let-7 microRNA drives these changes through acting on other key gene regulators, including EZH2 that covers the expression of a variation of genes, cell development and differentiation.
Findings are indicative of the let-7 microRNA as sufficient and essential to driving maturity of stem cell-derived cardiomyocytes, and that it holds a potential to mature cells in a laboratory dish with the simple addition of a cocktail of microRNAs and infused into cell culture.